Favipiravir

CHEMBL221722 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

157.1 g/mol

LogP

-0.6

Phase

4

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Peso Molecular

157,1000 g/mol

LogP

-0,60

TPSA

84,60 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Infectious Disease Gastroesophageal Reflux Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

NC(=O)c1nc(F)cnc1O

InChI

InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)

Molecular Formula

C5H4FN3O2

HBD / HBA

2 / 4

Ligações Rotacionáveis

1

Átomos Pesados

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Yes, Favipiravir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL221722. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 492405. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Favipiravir no PillFYI

Estrutura

Dados Rápidos

Fórmula: C5H4FN3O2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.